MedPage Today April 5, 2025
— Responsible, well-regulated innovation is the need of the hour
23andMe has gone bankruptopens in a new tab or window. If it is tempting to treat this failure as just another Silicon Valley experiment gone bad, do not be fooled. This bankruptcy provides an essential opportunity for digital health and health data innovators — one that should compel us to contemplate the fragile intersection between innovation, data privacy, and ethics.
Indeed, the 23andMe bankruptcy presents a case study in both the power and peril of data, particularly when that data is deeply personal. The essential question at hand is: What happens to your unique information — your genetic code — when the company holding it collapses?
A Company Built on...
Today's Sponsors
Today's Sponsor